Literature DB >> 14579085

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Young-Jin Kim1, Mijin Yun, Woo Jung Lee, Kyung Sik Kim, Jong Doo Lee.   

Abstract

Surgical resection is the only curative treatment strategy for intrahepatic cholangiocarcinoma (CC). Therefore, accurate staging is essential for appropriate management of patients with CC. We assessed the usefulness of 2-[(18)F]fluoro-2-deoxy- d-glucose (FDG) positron emission tomography (PET) in the staging of CC. We undertook a retrospective review of FDG PET images in 21 patients (10 female, 11 male; mean age 57 years) diagnosed with CC. Ten patients had hilar CC and 11, peripheral CC. Patients underwent abdominal magnetic resonance imaging (MRI) ( n=20) and computed tomography (CT) ( n=12) for the evaluation of primary tumours, and chest radiography and whole-body bone scintigraphy for work-up of distant metastases. For semi-quantitative analysis, the maximum voxel standardised uptake value (SUV(max)) was obtained from the primary tumour. All peripheral CCs showed intensely increased FDG uptake, and some demonstrated ring-shaped uptake corresponding to peripheral rim enhancement on CT and/or MRI. In nine of the ten patients, hilar CCs demonstrated increased FDG uptake of a focal nodular or linear branching appearance. The remaining case was false negative on FDG PET. One patient with a false negative result on MRI demonstrated increased uptake on FDG PET. Among the ten hilar CCs, FDG uptake was intense in only two patients and was slightly higher than that of the hepatic parenchyma in the remaining patients. For the detection of lymph node metastasis, FDG PET and CT/MRI were concordant in 16 patients, and discordant in five (FDG PET was positive in three, and CT and MRI in two). FDG PET identified unsuspected distant metastases in four of the 21 patients; all of these patients had peripheral CC. FDG PET is useful in detecting the primary lesion in both hilar and peripheral CC and is of value in discovering unsuspected distant metastases in patients with peripheral CC. FDG PET could be useful in cases of suspected hilar CC with non-confirmatory biopsy and radiological findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579085     DOI: 10.1007/s00259-003-1297-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  21 in total

1.  Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.

Authors:  S Keiding; S B Hansen; H H Rasmussen; A Gee; A Kruse; K Roelsgaard; U Tage-Jensen; J F Dahlerup
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

2.  A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading.

Authors:  T Nakajima; Y Kondo; M Miyazaki; K Okui
Journal:  Hum Pathol       Date:  1988-10       Impact factor: 3.466

3.  Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

Authors:  R Kluge; F Schmidt; K Caca; H Barthel; S Hesse; P Georgi; A Seese; D Huster; F Berr
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

4.  Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

Authors:  Takashi Kato; Eriko Tsukamoto; Yuji Kuge; Chietsugu Katoh; Toshikazu Nambu; Aichiro Nobuta; Satoshi Kondo; Masahiro Asaka; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-01       Impact factor: 9.236

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

Authors:  S Worawattanakul; R C Semelka; T C Noone; B F Calvo; N L Kelekis; J T Woosley
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

7.  Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation.

Authors:  P R Ros; J L Buck; Z D Goodman; A M Ros; W W Olmsted
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

8.  Liver transplantation for primary hepatic cancer.

Authors:  C E Haug; R L Jenkins; R J Rohrer; H Auchincloss; F L Delmonico; R B Freeman; W D Lewis; A B Cosimi
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

9.  Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.

Authors:  S Okazumi; K Isono; K Enomoto; T Kikuchi; M Ozaki; H Yamamoto; H Hayashi; T Asano; M Ryu
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

10.  Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma.

Authors:  P Soyer; D A Bluemke; R Reichle; P S Calhoun; D F Bliss; A Scherrer; E K Fishman
Journal:  AJR Am J Roentgenol       Date:  1995-12       Impact factor: 3.959

View more
  40 in total

1.  [Radiological diagnosis of Klatskin's tumour].

Authors:  S Pauls; M S Juchems; H-J Brambs
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

2.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

3.  Intrahepatic cholangiocarcinoma.

Authors:  Kimberly M Brown; Abhishek D Parmar; David A Geller
Journal:  Surg Oncol Clin N Am       Date:  2014-04       Impact factor: 3.495

Review 4.  Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Authors:  Han Zhang; Feng Shen; Jun Han; Yi-Nan Shen; Guo-Qiang Xie; Meng-Chao Wu; Tian Yang
Journal:  Hepat Oncol       Date:  2015-11-30

Review 5.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

6.  Intrahepatic cholangiocarcinoma: are we doing the right thing?

Authors:  Basile Njei
Journal:  Gastrointest Cancer Res       Date:  2014-01

7.  FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

Authors:  Koji Murakami
Journal:  World J Clin Oncol       Date:  2011-05-10

8.  FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.

Authors:  Anthony T Ruys; Roel J Bennink; Henderik L van Westreenen; Marc R Engelbrecht; Olivier R Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

Review 9.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 10.  Cross-sectional imaging of biliary tumors: current clinical status and future developments.

Authors:  Christoph J Zech; Stefan O Schoenberg; Maximilian Reiser; Thomas Helmberger
Journal:  Eur Radiol       Date:  2004-04-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.